DKSH Holding AG Expands Precision Healthcare in Asia with Launch of LIFE-SEQ Genomic Program in Thailand

Reuters
2025/09/15
DKSH Holding AG Expands Precision Healthcare in Asia with Launch of LIFE-SEQ Genomic Program in Thailand

DKSH Holding AG, a leading provider of market expansion services, has announced a significant expansion in the realm of genomic healthcare by partnering with PacBio and Chulalongkorn University to launch "LIFE-SEQ," Asia's first genomic program for precision health. This initiative utilizes advanced HiFi genome sequencing technology to offer lifelong care starting from newborn screening and rare disease detection. As the exclusive distributor of PacBio in Thailand, DKSH is facilitating access to this cutting-edge technology and has assembled a team of genomics experts. In its initial phase, the program will provide free sequencing for 300 newborns at Chulalongkorn University's Faculty of Medicine, with plans to expand nationwide. This expansion marks a milestone in precision healthcare, aiming to deliver genomic benefits for people of all ages across Thailand.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DKSH Holding AG published the original content used to generate this news brief on September 15, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10